Raymond James Financial’s AtriCure ATRC Stock Holding History
Bought
Maintained
Sold
Other funds holding ATRC
Raymond James Financial's ATRC Position: Q3 2026 in Review
Raymond James Financial reduced its AtriCure (ATRC) stake by 17% in Q3 2026, selling an estimated $2.05M and leaving 220,525 shares worth $12.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1942.
Raymond James Financial first reported a position in ATRC in Q4 2024 and has held it in 8 quarters since. 286 funds tracked by Wall St. Rank hold ATRC as of Q3 2026.
- Raymond James Financial held 220,525 shares of AtriCure worth $12.4M as of Q3 2026.
- Raymond James Financial sold 45,530 AtriCure shares in Q3 2026, an estimated $2.05M.
- AtriCure made up ﹤0.01% of Raymond James Financial's portfolio in Q3 2026, its #1942 holding.
- Raymond James Financial first reported a position in AtriCure in Q4 2024 and has held it in 8 quarters since.
- 286 funds tracked by Wall St. Rank held AtriCure as of Q3 2026.
Based on Raymond James Financial's 13F filing for Q3 2026, filed 12 Nov 2026.